TC BioPharm (Holdings) plc American Depositary Shares
TCBP
TCBP was delisted on the 21st of March, 2025.
1 hedge funds and large institutions have $1 invested in TC BioPharm (Holdings) plc American Depositary Shares in 2025 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
50% less funds holding
Funds holding: 2 → 1 (-1)
99% less capital invested
Capital invested by funds: $120 → $1 (-$119)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GI
GAMMA Investing
Foster City,
California
|
-$82 |
| 2 |
RhumbLine Advisers
Boston,
Massachusetts
|
-$37 |
TCBP Hedge Fund Activity: Q3 2025 in Review
1 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in TC BioPharm (Holdings) plc American Depositary Shares (TCBP) for Q3 2025, worth a combined $1 — down 99% from $120 a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of TCBP and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest seller was GAMMA Investing, exiting entirely with an estimated $82 sold.
- 1 institutional investor held TC BioPharm (Holdings) plc American Depositary Shares (TCBP) as of Q3 2025, down from 2 in Q2 2025.
- Funds reported $1 of TC BioPharm (Holdings) plc American Depositary Shares stock for Q3 2025, down 99% quarter-over-quarter.
- 0 funds opened new TC BioPharm (Holdings) plc American Depositary Shares positions in Q3 2025 and 1 closed out, a net change of -1 holder.
- The largest TC BioPharm (Holdings) plc American Depositary Shares seller in Q3 2025 was GAMMA Investing, an estimated $82 sold.
Based on aggregated 13F filings for Q3 2025.